Solifenacin succinate suspension 5 mg

DRUG2 trials

Sponsors

Astellas Pharma Inc

Conditions

Neurogenic Detrusor OveractivityOveractive BladderUrinary Bladder, Overactive

Phase 1

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents

CompletedNCT01262391

Astellas Pharma IncUrinary Bladder, Overactive

Start: 2010-10-20End: 2011-08-14Updated: 2024-10-22

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

CompletedNCT01539707

Astellas Pharma IncNeurogenic Detrusor Overactivity, Overactive Bladder

Start: 2012-03-13End: 2012-08-13Updated: 2024-10-22